Please login to the form below

Not currently logged in
Email:
Password:

Auden Mckenzie

This page shows the latest Auden Mckenzie news and features for those working in and with pharma, biotech and healthcare.

Actavis claims top UK generics spot with Auden Mckenzie buy

Actavis claims top UK generics spot with Auden Mckenzie buy

The Irish firm claims that when the Allergan and Auden Mckenzie deals close it will become the third-largest pharmaceutical manufacturer in the UK. ... Shareholders in Auden Mckenzie will also get a two-year royalty on a percentage of gross profits for

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Asset acquisition. 470. Auden Mckenzie/Actavis. Purchase includes generic portfolio of 175 products making Actavis no 1 generic supplier in the UK.

  • Pharma deals during January 2015 Pharma deals during January 2015

    In particular, it is good to also be able to report on a deal where one of the DW team has played a role; Roger Davies advised Auden McKenzie on the

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

David Atkins
A snapshot of Congenica
PME talks to CEO David Atkins...
Data desires
What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...

Infographics